In the current study, we performed immunohistochemical analysis for IDO expression in a total of 80 tissue samples of endometrial cancer, and demonstrated that high IDO expression was a reliable indicator for disease progression and the poor prognosis of endometrial cancer. This evidence concerns the gene IDO1 and endometrial cancer.